What is the recommended dosage and administration protocol for anti-snake venom (antivenom)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anti-Snake Venom Administration Protocol

The recommended initial dose of Anti-Snake Venom (ASV) for treating a snake bite is 10 vials administered intravenously, which provides optimal efficacy while minimizing the risk of adverse reactions. 1

Initial Assessment and Preparation

  • Ensure airway management and ventilatory support if needed, especially for neurotoxic envenomation 1
  • Remove rings and other constricting objects from the bitten extremity to prevent damage from swelling 1
  • Perform hypersensitivity testing before administering ASV to reduce risk of allergic reactions 1

Administration Protocol

  • Administer ASV intravenously as the preferred route for rapid distribution of antivenom 1
  • For most pit viper envenomations in North America, 12 vials is the recommended initial quantity to have available, though 10 vials is typically sufficient for initial treatment 2
  • For specific species like common krait, the recommended initial dose is 10 vials 3

Monitoring and Additional Dosing

  • Monitor for progressive venom injury (worsening local swelling, ecchymosis, coagulation abnormalities, or systemic effects) 4
  • Additional doses may be required for marked progressive local signs or if systemic manifestations persist 5
  • Be vigilant for potential recurrence of venom effects due to the shorter half-life of some antivenom preparations 4

Managing Adverse Reactions

  • Watch for potential adverse reactions including anaphylaxis (3.7% of cases) and serum sickness (3.7% of cases) 5
  • Have epinephrine readily available for treatment of anaphylactic reactions 2
  • The recommended dose of epinephrine for anaphylaxis is 0.01 mg/kg in children (up to 0.3 mg) and 0.3 to 0.5 mg in adults, preferably administered intramuscularly in the anterolateral thigh 2

Dosing Considerations

  • Evidence suggests that higher initial doses (10-20 vials) may be more effective in preventing coagulopathy complications compared to lower doses (4-6 vials) 6
  • However, for neurotoxic snake envenoming, research indicates that low-dose protocols may be as effective as high-dose protocols 7
  • Insufficient antivenom dosing can lead to persistent free venom and severe complications such as rhabdomyolysis 8

Hospital Preparedness

  • Hospitals should perform a hazard vulnerability assessment to determine appropriate stocking levels of antivenom 2
  • Geographic location and endemic venomous snake species should guide hospital stocking decisions 2
  • Consider the potential need for treating multiple bite victims simultaneously when determining stocking quantities 2

References

Guideline

Anti-Snake Venom Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anti-Snake Venom Dosage and Management for Common Krait Bite

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of antivenom therapy in Vipera palaestinae bites.

Toxicon : official journal of the International Society on Toxinology, 2004

Research

Dosage comparison of snake anti-venomon coagulopathy.

Iranian journal of pharmaceutical research : IJPR, 2014

Research

Severe rhabdomyolysis from red-bellied black snake (Pseudechis porphyriacus) envenoming despite antivenom.

Toxicon : official journal of the International Society on Toxinology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.